These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37250185)

  • 21. Prevalence and types of persistent dyslipidemia in patients treated with statins.
    Reiner Ž; Tedeschi-Reiner E
    Croat Med J; 2013 Aug; 54(4):339-45. PubMed ID: 23986274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
    Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
    Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
    Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
    BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study.
    Danon-Hersch N; Marques-Vidal P; Bovet P; Chiolero A; Paccaud F; Pécoud A; Hayoz D; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):66-72. PubMed ID: 19188810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys.
    Bays HE; Chapman RH; Grandy S;
    Int J Clin Pract; 2007 May; 61(5):737-47. PubMed ID: 17493087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.
    Shirani S; Kelishadi R; Sarrafzadegan N; Khosravi A; Sadri G; Amani A; Heidari S; Ramezani MA
    East Mediterr Health J; 2009; 15(6):1455-63. PubMed ID: 20218138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population.
    Berber A; Gómez-Santos R; Fanghänel G; Sánchez-Reyes L
    Int J Obes Relat Metab Disord; 2001 Dec; 25(12):1794-9. PubMed ID: 11781760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.
    Katundu KGH; Mukhula V; Phiri T; Phiri C; Filisa-Kaphamtengo F; Chipewa P; Chirambo G; Mipando M; Mwandumba HC; Muula AS; Kumwenda J
    BMC Cardiovasc Disord; 2022 Dec; 22(1):557. PubMed ID: 36544081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delphi consensus on management of dyslipidaemia in patients with impaired glucose metabolism: Diana study].
    Pedro-Botet J; Barrios V; Pascual V; Ascaso JF; Cases A; Millán J; Serrano A; Pintó X
    Clin Investig Arterioscler; 2016; 28(3):132-40. PubMed ID: 26949071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS).
    Marques da Silva P; Massano Cardoso S; Ferreira AM;
    Prim Care Diabetes; 2015 Aug; 9(4):283-9. PubMed ID: 25449144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-four-year trends and determinants of change in compliance with Swiss dietary guidelines.
    Schneid Schuh D; Guessous I; Gaspoz JM; Theler JM; Marques-Vidal P
    Eur J Clin Nutr; 2019 Jun; 73(6):859-868. PubMed ID: 30116035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of certain risk factors among dyslipidaemic patients, morbid with first episode coronary heart disease.
    Vinod RK; Shashikala M; Suresh KP
    J Indian Med Assoc; 2013 Jun; 111(6):391-4. PubMed ID: 24761497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid levels and the use of lipid-lowering agents in England and Scotland.
    Primatesta P; Poulter NR
    Eur J Cardiovasc Prev Rehabil; 2004 Dec; 11(6):484-8. PubMed ID: 15580059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
    BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, awareness, treatment and control of type 2 diabetes and its determinants among Mongolians in China: a cross-sectional analysis of IMAGINS 2015-2020.
    Duan M; Xi Y; Tian Q; Na B; Han K; Zhang X; Wang W; Zheng D; Wang Y
    BMJ Open; 2022 Nov; 12(11):e063893. PubMed ID: 36319058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumption of energy-dense diets in relation to cardiometabolic abnormalities among Iranian women.
    Esmaillzadeh A; Boroujeni HK; Azadbakht L
    Public Health Nutr; 2012 May; 15(5):868-75. PubMed ID: 22008550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study.
    Jameson K; Amber V; D'Oca K; Mills D; Giles A; Ambegaonkar B
    Int J Clin Pract; 2013 Dec; 67(12):1228-37. PubMed ID: 23944233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.